AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 289: F514-F520, 2005. First published April 19, 2005; doi:10.1152/ajprenal.00101.2005
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/3/F514    most recent
00101.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, F.
Right arrow Articles by Price, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, F.
Right arrow Articles by Price, P. M.

EDITORIAL FOCUS

Identification of the functional domain of p21WAF1/CIP1 that protects cells from cisplatin cytotoxicity

Fang Yu, Judit Megyesi, Robert L. Safirstein, and Peter M. Price

Departments of Physiology and Biophysics and Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Submitted 16 March 2005 ; accepted in final form 14 April 2005

The p21 cyclin-dependent kinase (cdk) inhibitor protects cells from cisplatin cytotoxicity in vivo and in vitro. However, the mechanism of protection is not known. Separate p21 domains are known to interact with several different proteins having proapoptotic functions. To investigate the mechanism of protection by p21, we have constructed adenoviruses encoding the different domains of p21. We were able to localize the protective activity to a region of 54 amino acids containing the cyclin-cdk interacting moiety. Other protein binding domains of p21, including the NH2-terminal procaspase-3 interactive region and the COOH-terminal region containing the proliferating cell nuclear antigen binding domain and the nuclear localization signal, had little protective effect on cisplatin cytotoxicity. The dependence of cisplatin cytotoxicity on cdk2 activity was also demonstrated because 1) cisplatin caused a marked increase in cdk2 activity, which was prevented by the p21 expression adenovirus, and 2) a cdk2 dominant-negative adenovirus also protected cells from cisplatin-induced apoptosis. Thus the data suggest that the mechanism of p21 protection is by direct inhibition of cdk2 activity and that cisplatin-induced apoptosis is caused by a cdk2-dependent pathway.

kidney proximal tubular cells; apoptosis; p21 cyclin kinase inhibitor; cdk2


Address for reprint requests and other correspondence: P. M. Price, Dept. of Internal Medicine, VA Medical Ctr., 4300 W. 7th St., Mail Route 151, Little Rock, AR 72205 (e-mail: pricepeterm{at}uams.edu)




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. Jiang and Z. Dong
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 300 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. Yu, J. Megyesi, and P. M. Price
Cytoplasmic initiation of cisplatin cytotoxicity
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F44 - F52.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. Sheikh-Hamad
Cisplatin-induced cytoxicity: is the nucleus relevant?
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F42 - F43.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Q. Wei, G. Dong, T. Yang, J. Megyesi, P. M. Price, and Z. Dong
Activation and involvement of p53 in cisplatin-induced nephrotoxicity
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1282 - F1291.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Garner, F. Martinon, J. Tschopp, P. Beard, and K. Raj
Cells with Defective p53-p21-pRb Pathway Are Susceptible to Apoptosis Induced by p84N5 via Caspase-6
Cancer Res., August 15, 2007; 67(16): 7631 - 7637.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. Yu, J. Megyesi, R. L. Safirstein, and P. M. Price
Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F52 - F59.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. Hochegger, C. Koppelstaetter, A. Tagwerker, J. M. Huber, D. Heininger, G. Mayer, and A. R. Rosenkranz
p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F762 - F768.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. Wang, N. Pabla, C.-Y. Wang, W. Wang, P. V. Schoenlein, and Z. Dong
Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1300 - F1307.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. M. Price, F. Yu, P. Kaldis, E. Aleem, G. Nowak, R. L. Safirstein, and J. Megyesi
Dependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2434 - 2442.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. A. Nath
Provenance of the protective property of p21
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F512 - F513.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.